Patient and physician preferences for type 2 diabetes medications: a systematic review

被引:30
|
作者
Toroski, Mahdi [1 ]
Kebriaeezadeh, Abbas [1 ,2 ,3 ]
Esteghamati, Alireza [4 ]
Karyani, Ali Kazemi [5 ]
Abbasian, Hadi [1 ]
Nikfar, Shekoufeh [1 ]
机构
[1] Univ Tehran Med Sci, Dept Pharmacoecon & Pharmaceut Adm, Fac Pharm, Tehran, Iran
[2] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Tehran, Iran
[3] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Vali Asr Hosp, Endocrinol & Metab Res Ctr EMRC, Tehran, Iran
[5] Kermanshah Univ Med Sci, Sch Publ Hlth, Kermanshah, Iran
关键词
Patient preferences; Diabetes type 2; Physician; Systematic review; DISCRETE-CHOICE EXPERIMENT; WILLINGNESS-TO-PAY; ADHERENCE; MELLITUS; MANAGEMENT; PEOPLE; HEALTH; ATTRIBUTES; COMPLICATIONS; IMPROVEMENTS;
D O I
10.1007/s40200-019-00449-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There are several treatments to cure type 2 diabetes (T2D) and every one of them has certain attributes which is lead patients and specialists to have different preferences and select power. Therefore, we did this systematic study to evaluate patients and physicians preferences for type 2 diabetes medications by extracting attributes of anti-diabetic medications and identifying their relative importance. Methods We searched the PubMed, Ovid, Web of science, Scopus and Embase databases for articles which have been published on or before May 8th, 2018(The start time of the search in our study was May 8th, 2018). Results The searches identified 3346 studies, of which 17 (from 2009 to 2017) were included in the final synthesis and 27 attributes of type 2 anti-diabetic have been investigated. The most important attributes are changes of blood glucose and HbA1c level, hypoglycemia events, weight changes, gastrointestinal complications, cardiovascular effects, medicines cost, and administration mode and dosage of medicines. Conclusion physicians and patients prefer antidiabetics which is reduce blood glucose and HbA1c level effectively and have low side effects too (hypoglycemic event, cardiovascular and gastrointestinal). The effect of weight reduction, low cost, low dosing and low frequency of using. Health care providers, Specialist, and manufacturers should consider to these attributes in treatment process and marketing. It can increase adherence to management approaches, and reduce morbidity of patients with type 2 diabetes.
引用
收藏
页码:643 / 656
页数:14
相关论文
共 50 条
  • [31] Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States
    Boye, Kristina S.
    Jordan, Jessica B.
    Malik, Raleigh
    Matza, Louis S.
    DIABETES THERAPY, 2024, 15 (02) : 381 - 393
  • [32] Adherence of patients with type 2 diabetes mellitus to medications: the role of risk preferences
    Simon-Tuval, Tzahit
    Shmueli, Amir
    Harman-Boehm, Ilana
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 345 - 351
  • [33] Physician's gender, communication style, patient preferences and patient satisfaction in gynecology and obstetrics: A systematic review
    Janssen, Sabine M.
    Lagro-Janssen, Antoine L. M.
    PATIENT EDUCATION AND COUNSELING, 2012, 89 (02) : 221 - 226
  • [34] Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion
    Pamela Kushner
    Anne Dalin
    Diabetes Therapy, 2023, 14 : 621 - 627
  • [35] Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments
    Poulos, Christine
    Gonzalez, Juan Marcos
    Lee, Lauren J.
    Boye, Kristin S.
    Johnson, F. Reed
    Bae, Jay P.
    Deeg, Mark A.
    DIABETES THERAPY, 2013, 4 (02) : 443 - 459
  • [36] Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments
    Christine Poulos
    Juan Marcos González
    Lauren J. Lee
    Kristin S. Boye
    F. Reed Johnson
    Jay P. Bae
    Mark A. Deeg
    Diabetes Therapy, 2013, 4 : 443 - 459
  • [37] Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review
    Anagnostis, Panagiotis
    Paschou, Stavroula A.
    Gkekas, Nifon N.
    Artzouchaltzi, Aikaterini-Maria
    Christou, Konstantinos
    Stogiannou, Dimitrios
    Vryonidou, Andromachi
    Potoupnis, Michael
    Goulis, Dimitrios G.
    ENDOCRINE, 2018, 60 (03) : 373 - 383
  • [38] Systematic Review of Pharmacist Interventions to Improve Adherence to Oral Antidiabetic Medications in People with Type 2 Diabetes
    Omran, Dima
    Guirguis, Lisa M.
    Simpson, Scot H.
    CANADIAN JOURNAL OF DIABETES, 2012, 36 (05) : 292 - 299
  • [39] Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review
    Panagiotis Anagnostis
    Stavroula A. Paschou
    Nifon N. Gkekas
    Aikaterini-Maria Artzouchaltzi
    Konstantinos Christou
    Dimitrios Stogiannou
    Andromachi Vryonidou
    Michael Potoupnis
    Dimitrios G. Goulis
    Endocrine, 2018, 60 : 373 - 383
  • [40] Patient preferences for newer oral therapies in type 2 diabetes
    Savarese, Gianluigi
    Sharma, Abhinav
    Pang, Christianne
    Wood, Richard
    Soleymanlou, Nima
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 371 : 526 - 532